Ronald Hunt's Net Worth

$215 Million

Who is Ronald Hunt?

Ronald Hunt has an estimated net worth of $215 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, iRhythm Technologies, Inc., Rallybio Corp, Harpoon Therapeutics, Inc., Oxford Immunotec Global PLC, CONCERT PHARMACEUTICALS, INC., Iterum Therapeutics plc, Neuronetics, Inc., MEI Pharma, Inc., Transcept Pharmaceuticals Inc, Durata Therapeutics, Inc., Versartis, Inc., CHIMERIX INC, ICAGEN INC, WORLD HEART CORP, and CORIXA CORP.

SEC CIK

Ronald Hunt's CIK is 0001247851

Past Insider Trading and Trends

2023 was Ronald Hunt's most active year for acquiring shares with 17 total transactions. Ronald Hunt's most active month to acquire stocks was the month of April. 2013 was Ronald Hunt's most active year for disposing of shares, totalling 15 transactions. Ronald Hunt's most active month to dispose stocks was the month of June. 2023 saw Ronald Hunt paying a total of $10,000,000.00 for 5,425,633 shares, this is the most they've acquired in one year. In 2014 Ronald Hunt cashed out on 40,588,403 shares for a total of $19,074,752.54, their largest year based on trade value.